期刊文献+

RNAi技术应用于妇科肿瘤治疗的研究进展 被引量:5

Research Progress on the Application of RNA Interference in Gynecological Cancer Therapy
下载PDF
导出
摘要 RNA干扰(RNA interference,RNAi)是一种在动植物中广泛存在的通过双链RNA(dsRNA)分子在mRNA水平上诱导特异性序列基因沉默的过程,即转录后基因沉默(post-transcriptional gene silencing,PTGS),由与被抑制基因同源的dsRNA启动。近年来,RNAi作为一种研究工具在生命科学领域得到了广泛的应用,其在医学领域中的应用尤为突出,不仅可应用于基础研究,还有望成为攻克肿瘤、病毒性疾病及遗传性疾病的新手段。现就RNAi应用于妇科肿瘤治疗的研究进展作一概述。 RNA interference (RNAi), induced by double-strand RNA homologous to the target gene, is a process of post-transcriptional gene silencing in animals and plants. It plays an important role in down-regulating the expression of the endogenous gene. As a useful technique, RNAi has been widely applied to the study of life science, especially in the field of medicine. It is not only advantageous in basic researches but also a promising technique in fighting tumors, viral infection and inherited diseases. This paper summarizes the mechanisms and characteristics of RNAi as well as the latest progress on its application in gene therapy of gynecological cancer.
出处 《临床医学工程》 2009年第5期100-103,共4页 Clinical Medicine & Engineering
关键词 RNA干扰 宫颈癌 卵巢癌 子宫内膜癌 RNA interference Uterine cervix cancer Ovarian cancer Endometrial cancer
  • 相关文献

参考文献1

  • 1Ni Sima,Wei Wang,Debo Kong,Dongrui Deng,Qian Xu,Jianfeng Zhou,Gang Xu,Li Meng,Yunping Lu,Shixuan Wang,Ding Ma. RNA interference against HPV16 E7 oncogene leads to viral E6 and E7 suppression in cervical cancer cells and apoptosis via upregulation of Rb and p53[J] 2008,Apoptosis(2):273~281

同被引文献50

  • 1赵卫红,郝敏.Stat3在妇科恶性肿瘤中的作用研究[J].中国妇幼健康研究,2007,18(5):440-443. 被引量:2
  • 2郭瑞霞,魏丽惠.磷脂酰肌醇3激酶/蛋白激酶B信号传导通路与妇科恶性肿瘤关系的研究进展[J].中华妇产科杂志,2005,40(5):358-360. 被引量:22
  • 3Klampfer L. Signal transducers and activators of transcription ( STATs ): Novel targets of chemopreventive and chemotherapeutic drugs [J]. Curr Cancer Drug Targets, 2006, 6 (2): 107-121.
  • 4Naora H, Silver D L, Liu transducer and activator of Localization in focal adhesions cell molitity [J]. Cancer Res, J, et al. Activated signal transcription ( STAT ) 3: and function in ovarian cancer 2004, 64 (10): 3550-3558.
  • 5Leeman RJ, Lui VW, Grandis JR. STAT3 as a therapeutic target in head and neck cancer [J]. Expert Opin Biol Ther, 2006, 6 (3): 231-241.
  • 6Hsieh FC, Cheng G, Lin J, et al. Evaluation of potential Stat3-regulated genes in human breast cancer [J]. Biochem Biophys Res Commun, 2005, 335 (2): 292-299.
  • 7Rosen DG, Mercado UI, Yang G, et al. The role of constitutively active signal transducer and activator of transcription 3 in ovarian tumorigenesis and prognosis [J]. Cancer, 2006, 107 (11): 2730-2740.
  • 8Lang C, Leslie K, Devgan G, et al. Cyclin D1 is transcriptionally regulated by and required for transformation by activated signal transducer and activator of transcription 3 [J]. Cancer Res, 2006, 66 (5): 2544-2552.
  • 9Williams A, Gritsko T, Turkson J. Persistent activation of Stat3 signaling induces Survivin gene expression and confers resistance to apoptosis in human breast cancer cells [J]. Clin Cancer Res, 2006, 12 (1): 11-19.
  • 10Zheng L, Le X, Wei D, et al. Stat3 activation regulates the expression of vascular endothelial growth factor and human pancreatic cancer angiogenesis and metastasis [J]. Oncogene, 2003, 22 (3): 319-329.

引证文献5

二级引证文献18

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部